▶ 調査レポート

セルメチニブの世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Selumetinib Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。セルメチニブの世界市場2020年:メーカー別、地域別、種類・用途別 / Global Selumetinib Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A8336資料のイメージです。• レポートコード:MRC2012A8336
• 出版社/出版日:GlobalInfoResearch / 2020年12月28日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、セルメチニブの世界市場を広く調査・分析し、今後の市場展望をまとめております。セルメチニブの種類別市場規模(10 mg、25 mg)、用途別市場規模(病院、診療所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):AstraZeneca、Merck
・地域別グローバル市場分析 2015年-2020年
・セルメチニブの北米市場(アメリカ、カナダ、メキシコ)
・セルメチニブのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・セルメチニブのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・セルメチニブの南米市場(ブラジル、アルゼンチン)
・セルメチニブの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:10 mg、25 mg
・用途別分析:病院、診療所、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Selumetinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Selumetinib market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Selumetinib market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Selumetinib market has been segmented into
10 mg
25 mg

By Application, Selumetinib has been segmented into:
Hospitals
Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Selumetinib market presented in the report. This section sheds light on the sales growth of different regional and country-level Selumetinib markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Selumetinib market.

The report offers in-depth assessment of the growth and other aspects of the Selumetinib market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Selumetinib Market Share Analysis
Selumetinib competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Selumetinib sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Selumetinib sales, revenue and market share for each player covered in this report.

The major players covered in Selumetinib are:
AstraZeneca
Merck

Among other players domestic and global, Selumetinib market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Selumetinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Selumetinib, with price, sales, revenue and global market share of Selumetinib in 2018 and 2019.
Chapter 3, the Selumetinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Selumetinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Selumetinib market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Selumetinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Selumetinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Selumetinib Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 10 mg
1.2.3 25 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Selumetinib Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Overview of Global Selumetinib Market
1.4.1 Global Selumetinib Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Selumetinib Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Selumetinib Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Selumetinib Manufacturer Market Share in 2019
3.3.2 Top 6 Selumetinib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Selumetinib Sales, Revenue and Market Share by Regions
4.1.1 Global Selumetinib Sales and Market Share by Regions (2015-2020)
4.1.2 Global Selumetinib Revenue and Market Share by Regions (2015-2020)
4.2 North America Selumetinib Sales and Growth Rate (2015-2020)
4.3 Europe Selumetinib Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Selumetinib Sales and Growth Rate (2015-2020)
4.5 South America Selumetinib Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Selumetinib Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Selumetinib Sales, Revenue and Market Share by Country
5.1.1 North America Selumetinib Sales and Market Share by Country (2015-2020)
5.1.2 North America Selumetinib Revenue and Market Share by Country (2015-2020)
5.2 United States Selumetinib Sales and Growth Rate (2015-2020)
5.3 Canada Selumetinib Sales and Growth Rate (2015-2020)
5.4 Mexico Selumetinib Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Selumetinib Sales, Revenue and Market Share by Country
6.1.1 Europe Selumetinib Sales and Market Share by Country (2015-2020)
6.1.2 Europe Selumetinib Revenue and Market Share by Country (2015-2020)
6.2 Germany Selumetinib Sales and Growth Rate (2015-2020)
6.3 UK Selumetinib Sales and Growth Rate (2015-2020)
6.4 France Selumetinib Sales and Growth Rate (2015-2020)
6.5 Russia Selumetinib Sales and Growth Rate (2015-2020)
6.6 Italy Selumetinib Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Selumetinib Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Selumetinib Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Selumetinib Revenue and Market Share by Regions (2015-2020)
7.2 China Selumetinib Sales and Growth Rate (2015-2020)
7.3 Japan Selumetinib Sales and Growth Rate (2015-2020)
7.4 Korea Selumetinib Sales and Growth Rate (2015-2020)
7.5 India Selumetinib Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Selumetinib Sales and Growth Rate (2015-2020)
7.7 Australia Selumetinib Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Selumetinib Sales, Revenue and Market Share by Country
8.1.1 South America Selumetinib Sales and Market Share by Country (2015-2020)
8.1.2 South America Selumetinib Revenue and Market Share by Country (2015-2020)
8.2 Brazil Selumetinib Sales and Growth Rate (2015-2020)
8.3 Argentina Selumetinib Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Selumetinib Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Selumetinib Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Selumetinib Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Selumetinib Sales and Growth Rate (2015-2020)
9.3 Turkey Selumetinib Sales and Growth Rate (2015-2020)
9.4 Egypt Selumetinib Sales and Growth Rate (2015-2020)
9.5 South Africa Selumetinib Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Selumetinib Sales and Market Share by Type (2015-2020)
10.2 Global Selumetinib Revenue and Market Share by Type (2015-2020)
10.3 Global Selumetinib Price by Type (2015-2020)
11 Global Selumetinib Market Segment by Application
11.1 Global Selumetinib Sales Market Share by Application (2015-2020)
11.2 Global Selumetinib Revenue Market Share by Application (2015-2020)
11.3 Global Selumetinib Price by Application (2015-2020)
12 Market Forecast
12.1 Global Selumetinib Sales, Revenue and Growth Rate (2021-2025)
12.2 Selumetinib Market Forecast by Regions (2021-2025)
12.2.1 North America Selumetinib Market Forecast (2021-2025)
12.2.2 Europe Selumetinib Market Forecast (2021-2025)
12.2.3 Asia-Pacific Selumetinib Market Forecast (2021-2025)
12.2.4 South America Selumetinib Market Forecast (2021-2025)
12.2.5 Middle East & Africa Selumetinib Market Forecast (2021-2025)
12.3 Selumetinib Market Forecast by Type (2021-2025)
12.3.1 Global Selumetinib Sales Forecast by Type (2021-2025)
12.3.2 Global Selumetinib Market Share Forecast by Type (2021-2025)
12.4 Selumetinib Market Forecast by Application (2021-2025)
12.4.1 Global Selumetinib Sales Forecast by Application (2021-2025)
12.4.2 Global Selumetinib Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Selumetinib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Selumetinib by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Selumetinib Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Selumetinib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Selumetinib Major Business
Table 10. AstraZeneca Selumetinib Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca SWOT Analysis
Table 12. AstraZeneca Selumetinib Product and Services
Table 13. AstraZeneca Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Merck Basic Information, Manufacturing Base and Competitors
Table 15. Merck Selumetinib Major Business
Table 16. Merck Selumetinib Total Revenue (USD Million) (2018-2019)
Table 17. Merck SWOT Analysis
Table 18. Merck Selumetinib Product and Services
Table 19. Merck Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Global Selumetinib Sales by Manufacturer (2018-2019) (K Units)
Table 21. Global Selumetinib Revenue by Manufacturer (2018-2019) (USD Million)
Table 22. Global Selumetinib Sales by Regions (2015-2020) (K Units)
Table 23. Global Selumetinib Sales Market Share by Regions (2015-2020)
Table 24. Global Selumetinib Revenue by Regions (2015-2020) (USD Million)
Table 25. North America Selumetinib Sales by Countries (2015-2020) (K Units)
Table 26. North America Selumetinib Sales Market Share by Countries (2015-2020)
Table 27. North America Selumetinib Revenue by Countries (2015-2020) (USD Million)
Table 28. North America Selumetinib Revenue Market Share by Countries (2015-2020)
Table 29. Europe Selumetinib Sales by Countries (2015-2020) (K Units)
Table 30. Europe Selumetinib Sales Market Share by Countries (2015-2020)
Table 31. Europe Selumetinib Revenue by Countries (2015-2020) (USD Million)
Table 32. Asia-Pacific Selumetinib Sales by Regions (2015-2020) (K Units)
Table 33. Asia-Pacific Selumetinib Sales Market Share by Regions (2015-2020)
Table 34. Asia-Pacific Selumetinib Revenue by Regions (2015-2020) (USD Million)
Table 35. South America Selumetinib Sales by Countries (2015-2020) (K Units)
Table 36. South America Selumetinib Sales Market Share by Countries (2015-2020)
Table 37. South America Selumetinib Revenue by Countries (2015-2020) (USD Million)
Table 38. South America Selumetinib Revenue Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Selumetinib Sales by Countries (2015-2020) (K Units)
Table 40. Middle East & Africa Selumetinib Sales Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Selumetinib Revenue by Countries (2015-2020) (USD Million)
Table 42. Middle East & Africa Selumetinib Revenue Market Share by Countries (2015-2020)
Table 43. Global Selumetinib Sales by Type (2015-2020) (K Units)
Table 44. Global Selumetinib Sales Share by Type (2015-2020)
Table 45. Global Selumetinib Revenue by Type (2015-2020) (USD Million)
Table 46. Global Selumetinib Revenue Share by Type (2015-2020)
Table 47. Global Selumetinib Sales by Application (2015-2020) (K Units)
Table 48. Global Selumetinib Sales Share by Application (2015-2020)
Table 49. Global Selumetinib Sales Forecast by Regions (2021-2025) (K Units)
Table 50. Global Selumetinib Market Share Forecast by Regions (2021-2025)
Table 51. Global Selumetinib Sales Forecast by Type (2021-2025) (K Units)
Table 52. Global Selumetinib Market Share Forecast by Type (2021-2025)
Table 53. Global Selumetinib Sales Forecast by Application (2021-2025)
Table 54. Global Selumetinib Market Share Forecast by Application (2021-2025)
Table 55. Direct Channel Pros & Cons
Table 56. Indirect Channel Pros & Cons
Table 57. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Selumetinib Picture
Figure 2. Global Sales Market Share of Selumetinib by Type in 2019
Figure 3. 10 mg Picture
Figure 4. 25 mg Picture
Figure 5. Selumetinib Sales Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Others Picture
Figure 9. Global Selumetinib Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Selumetinib Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Selumetinib Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Selumetinib Sales Market Share by Manufacturer in 2019
Figure 30. Global Selumetinib Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Selumetinib Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Selumetinib Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Selumetinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Selumetinib Revenue Market Share by Regions (2015-2020)
Figure 37. Global Selumetinib Revenue Market Share by Regions in 2018
Figure 38. North America Selumetinib Sales and Growth Rate (2015-2020)
Figure 39. Europe Selumetinib Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Selumetinib Sales and Growth Rate (2015-2020)
Figure 41. South America Selumetinib Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Selumetinib Sales and Growth Rate (2015-2020)
Figure 43. North America Selumetinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Selumetinib Sales Market Share by Countries (2015-2020)
Figure 45. North America Selumetinib Sales Market Share by Countries in 2018
Figure 46. North America Selumetinib Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Selumetinib Revenue Market Share by Countries in 2018
Figure 48. United States Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Selumetinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Selumetinib Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Selumetinib Revenue Market Share by Countries in 2019
Figure 54. Germany Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Selumetinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Selumetinib Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Selumetinib Revenue Market Share by Regions 2019
Figure 62. China Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Selumetinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Selumetinib Sales Market Share by Countries in 2019
Figure 69. South America Selumetinib Revenue Market Share by Countries in 2019
Figure 70. Brazil Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Selumetinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Selumetinib Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Selumetinib Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Selumetinib Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Selumetinib Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Selumetinib Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Selumetinib Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Selumetinib Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Selumetinib Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Selumetinib Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Selumetinib Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Selumetinib Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel